Diff Profiles › MTBLS125_0002_00000005

Control_Oral_Blood_vs_RESV_Oral_Blood

Control_Oral_Blood vs RESV_Oral_Blood

p-value ≤ 0.05 1 significant 2025-09-26 00:00:00 Study: MTBLS125
116 Total Features
1 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS125_0002_00000005
Linked study
MTBLS125 — Distribution of RESV and its metabolite peaks in mouse tissues after oral and skin administration
Comparison
Control_Oral_Blood vs RESV_Oral_Blood
Group A
Control group for oral administration in blood samples. Provides baseline for comparison with RESV oral treatment in blood
Group B
RESV treatment group for oral administration in blood samples. Evaluates the effect of RESV oral treatment in blood
Total features tested
116
Significant features
1
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
BXFFHSIDQOFMLE-UHFFFAOYSA-N 3-indolyl sulfate up 1.975 0.0394